Hemostemix, Inc.
http://www.hemostemix.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Hemostemix, Inc.
Deal Watch: Roivant Adds Ligand's Glucose Receptor Antagonist To Metavant Pipeline
Celgene will pursue "high-impact" indications using Vividion's proteomics technology, while Magenta will use Heidelberg's technology to try to optimize bone marrow transplants.
Execs On The Move, December 2014
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Execs On The Move, October 2014
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Recent Financings Of Private Companies, April 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
-
- TheraVitae, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice